ABT-116
ABT-116 is an orally active antagonist of transient receptor potential vanilloid type 1 (TRPV1) . ABT-116 has analgesic efficacy. ABT-116 can be used for the research of neurological disease[1].
Product Specifications
CAS Number
[1008529-42-7]
UNSPSC
12352005
Target
TRP Channel
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C(NCC1=CC=C(C(F)(F)F)C=C1CCC(C)(C)C)NC2=CC=CC3=C2C=NN3C
Molecular Formula
C23H27F3N4O
Molecular Weight
432.48
References & Citations
[1]Niyom S, et al. Comparison of the analgesic efficacy of oral ABT-116 administration with that of transmucosal buprenorphine administration in dogs. Am J Vet Res. 2012 Apr;73 (4) :476-81.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TRPV1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6200311-01 0.1 mL
CSNK1D (Casein Kinase I, delta Isoform, CKI-delta, CKId) (MaxLight 490)
Ask
View Details MBS6200311-02 5x 0.1 mL
CSNK1D (Casein Kinase I, delta Isoform, CKI-delta, CKId) (MaxLight 490)
Ask
View Details ![Rabbit Polyclonal PGRMC2 Antibody [Alexa Fluor 594]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
